ACC: Semaglutide Beneficial in Patients With T2DM and Peripheral Artery Disease
Semaglutide associated with increased walking distance in patients with symptomatic peripheral artery disease and type 2 diabetes
Similar Mortality Benefit Seen for Concentrated, Evenly Spread Physical Activity
Similar reduction seen in mortality risk for MVPA concentrated within one to two days versus more evenly spread pattern
ACC: Cardiac Arrest Incidence at Long-Distance Races Remains Stable
There has been a marked decline in cardiac arrest mortality during the last decade
ACC: Microplastic Exposure Tied to Chronic Disease Prevalence
Significant associations seen for high blood pressure, diabetes, and stroke
ACC: 1999 to 2022 Saw Increase in Maternal Mortality Due to CVD
Age-adjusted mortality rate from CVD-related mortality increased from 3.62 to 9.08 per 100,000 among women aged 15 to 44 years
FDA Removes Top Expert on Vaping and Tobacco
Subclinical Cardiac Dysfunction Linked to Markers of Neurodegeneration
Consistent association seen for markers of systolic dysfunction with smaller total brain volume
Speed of Resuscitation Critical to Survival Outcomes After Cardiac Arrest Events
Predictors of in-hospital mortality include worse LVEF, longer time to return of spontaneous circulation, older age
Persistently High Stroke Risk Seen After TIA, Minor Stroke
Cumulative incidence of stroke was 12.5 percent at five years, 19.8 percent at 10 years
Weight Loss Greater With Intermittent Fasting Than Calorie Restriction
Weight loss moderately greater with 4:3 IMF versus daily calorie restriction in adults with overweight, obesity
